.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Novartis
McKesson
AstraZeneca
Cerilliant
Express Scripts
QuintilesIMS
Citi
Harvard Business School
Argus Health

Generated: July 24, 2017

DrugPatentWatch Database Preview

Aqua Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for AQUA PHARMS, and when can generic versions of AQUA PHARMS drugs launch?

AQUA PHARMS has eleven approved drugs.

There are twelve US patents protecting AQUA PHARMS drugs.

There are one hundred and forty-seven patent family members on AQUA PHARMS drugs in thirty-seven countries.

Summary for Applicant: Aqua Pharms

Patents:12
Tradenames:11
Ingredients:9
NDAs:11
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aqua Pharms Llc
ACTICLATE
doxycycline hyclate
TABLET;ORAL205931-001Jul 25, 2014ABRXYesNo► Subscribe► Subscribe► Subscribe
Aqua Pharms
CORDRAN
flurandrenolide
OINTMENT;TOPICAL012806-001Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe
Aqua Pharms
XOLEGEL
ketoconazole
GEL;TOPICAL021946-001Jul 28, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
Aqua Pharms
MONODOX
doxycycline
CAPSULE;ORAL050641-002Feb 10, 1992ABRXYesNo► Subscribe► Subscribe► Subscribe
Aqua Pharms Llc
ACTICLATE
doxycycline hyclate
TABLET;ORAL205931-002Jul 25, 2014ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Aqua Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aqua Pharms
SOLAGE
mequinol; tretinoin
SOLUTION;TOPICAL020922-001Dec 10, 1999► Subscribe► Subscribe
Aqua Pharms Llc
VELTIN
clindamycin phosphate; tretinoin
GEL;TOPICAL050803-001Jul 16, 2010► Subscribe► Subscribe
Aqua Pharms
SOLAGE
mequinol; tretinoin
SOLUTION;TOPICAL020922-001Dec 10, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Aqua Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,281,226 Pleuromutilin derivatives as antimicrobials► Subscribe
8,263,580Vitamin formulation► Subscribe
RE39128Pleuromutilin derivatives as antimicrobials► Subscribe
8,629,128Vitamin formulation► Subscribe
8,449,867Microemulsion and sub-micron emulsion process and compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Aqua Pharms Drugs

Country Document Number Estimated Expiration
China100341578► Subscribe
China101048136► Subscribe
European Patent Office1452534► Subscribe
Japan2007504231► Subscribe
AustraliaPP583198► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Aqua Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
C042/2007Ireland► SubscribeSPC042/2007: 20080415, EXPIRES: 20220523
13/044Ireland► SubscribePRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
C/GB02/033United Kingdom► SubscribePRODUCT NAME: FORMOTEROL (OPTIONALLY IN THE FORM OF THE FREE BASE OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE OF SUCH FREE BASE OR SALT ESPECIALLY AS FORMOTEROL FUMARATE DIHYDRATE) AND BUDESONIDE; REGISTERED: SE SE16047, 16048 20000825; UK PL17901/0091 20010515; UK PL17901/0092 20010515
401Luxembourg► SubscribePRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Merck
Deloitte
QuintilesIMS
Teva
McKesson
Boehringer Ingelheim
Chinese Patent Office
Federal Trade Commission
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot